First Light Biosciences Develops a Novel Method for Rapidly Determining Effective Antibiotics for Treating Infections
First Light Biosciences, a provider of innovative diagnostic tests for fighting life-threatening i…
First Light Biosciences, a provider of innovative diagnostic tests for fighting life-threatening i…
A test that may reduce, from days to hours, the time needed to diagnose patients with bacterial in…
As Part of national efforts to improve the diagnosis of tuberculosis (TB), the Minister of Health,…
OpGen, Inc. announced a groundbreaking collaboration with the New York State Department of Healt…
Global pharmaceutical company Mylan N.V. and medical device company Atomo Diagnostics today announ…
In a potential game changer for the health care industry, a new cell phone app and lab kit now all…
Cepheid announced the CE-IVD marking of Xpert HCV VL Fingerstick, the first molecular test to dete…
About 40 percent of clinically abnormal milk samples tested with traditional bacterial culture com…
QIAGEN N.V. and NeuMoDx Molecular, Inc. announced a strategic partnership to commercialize two new…
A £3 million interdisciplinary research project is to address the growing threat of drug-resistant…
IDEXX Laboratories, Inc., the global leader in rapid microbiological testing for water, today anno…
Curetis N.V., a developer of next-level molecular diagnostic solutions, today announced that its w…
As part of its Horizon 2020 research and innovation program, the European Union has agreed to supp…
Quidel, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molec…